SCHEMBL20022136

SCHEMBL20022136

COc1ccc(-c2cccc(-c3cccc(-c4cccc(C)c4)c3)c2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.69
ABCB1 P08183 2/20 0.69
BCR P11274 2/20 0.69
ACHE P22303 2/20 0.57
CYP1A1 P04798 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2E1 P05181 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C8 P10632 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2A6 P11509 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP4B1 P13584 1/20 0.55
CYP2B6 P20813 1/20 0.55
CYP3A5 P20815 1/20 0.55
CYP2A7 P20853 1/20 0.55
CYP3A7 P24462 1/20 0.55
CYP2F1 P24903 1/20 0.55
CYP2C18 P33260 1/20 0.55
CYP2C19 P33261 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20022108 1.00 ABL1 (0.69) ABL1ABCB1BCRACHECYP1A1
SCHEMBL20022095 0.98 ABL1 (0.72) ABL1ABCB1BCRACHECYP1A1
SCHEMBL1133171 0.98 ABL1 (0.66) ABL1ABCB1BCRACHECYP1A1
SCHEMBL12871363 0.98 ABL1 (0.66) ABL1ABCB1BCRACHECYP1A1
SCHEMBL12871359 0.90 ABL1 (0.71) ABL1ABCB1BCRACHECYP1A1
SCHEMBL1180429 0.89 ABL1 (0.83) ABL1ABCB1BCRCYP1A1CYP1A2
SCHEMBL12871360 0.88 ACHE (0.69) ABL1ABCB1BCRACHECYP1A1
SCHEMBL20022115 0.86 ACHE (0.72) ABL1ABCB1BCRACHECYP1A1
SCHEMBL20022092 0.86 ACHE (0.72) ABL1ABCB1BCRACHECYP1A1
SCHEMBL11254405 0.85 ACHE (0.68) ABL1ABCB1BCRACHECYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10689402-B2 Polycyclic aromatic compound and light emission layer-forming composition JNC CORPORATION (JP) 2020-06-23 US disclosed
US-20180094000-A1 POLYCYCLIC AROMATIC COMPOUND AND LIGHT EMISSION LAYER-FORMING COMPOSITION KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2018-04-05 US disclosed
US-20180094000-A1 POLYCYCLIC AROMATIC COMPOUND AND LIGHT EMISSION LAYER-FORMING COMPOSITION KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2018-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180094000-A1 POLYCYCLIC AROMATIC COMPOUND AND LIGHT EMISSION LAYER-FORMING COMPOSITION TYR, NOD2, AHR ABL1 681/4885ABCB1 195/4885BCR 1274/4885
US-10689402-B2 Polycyclic aromatic compound and light emission layer-forming composition TYR, NOD2, AHR ABL1 681/4885ABCB1 195/4885BCR 1274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.